Harrow Health Inc
Change company Symbol lookup
Select an option...
HROW Harrow Health Inc
UPC Universe Pharmaceuticals Inc
MHH Mastech Digital Inc
GCTK GlucoTrack Inc
KODK Eastman Kodak Co
FYBR Frontier Communications Parent Inc
TPNEF Cub Energy Inc
ECC Eagle Point Credit Co LLC
CPHI China Pharma Holdings Inc
SHOP Shopify Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Harrow Health, Inc. is an ophthalmic-focused healthcare company. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, Inc. (Visionology), a direct-to-consumer eye care subsidiary focused on chronic eye disease. In addition, the Company holds non-controlling equity positions in Surface Ophthalmics, Inc. (Surface) and Melt Pharmaceuticals, Inc. (Melt). It also owns royalty rights in various drug candidates being developed by Surface and Melt.

Closing Price
$8.44
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
66,952
0

Lifshitz Law PLLC Announces Investigation of CTEK, MANT, ETTX and VMW

8:11 pm ET June 4, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / June 4, 2022 /

CynergisTek, Inc. (NYSE:CTEK)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of CTEK to Clearwater Compliance LLC for $1.25 per share in cash.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ManTech International Corporation (NASDAQGS:MANT)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of MANT to a private equity consortium led by The Carlyle Group Inc. for $96.00 in cash per share of MANT owned.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of ETTX to Innoviva, Inc. for $2.20 per share in cash.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

VMware, Inc. (NYSE:VMW)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of VMW to Broadcom Inc. Under the terms of the proposed transaction, shareholders of VMW will elect to receive either $142.50 in cash or 0.2520 shares of Broadcom common stock for each share of VMW they own.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2022 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: info@jlclasslaw.com

SOURCE: Lifshitz Law PLLC





View source version on accesswire.com:

https://www.accesswire.com/703874/Lifshitz-Law-PLLC-Announces-Investigation-of-CTEK-MANT-ETTX-and-VMW



comtex tracking

COMTEX_408219974/2457/2022-06-04T20:11:36

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.